These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26398237)
41. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management. Reisfield GM; Goldberger BA; Bertholf RL J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163 [TBL] [Abstract][Full Text] [Related]
42. Rational use and interpretation of urine drug testing in chronic opioid therapy. Reisfield GM; Salazar E; Bertholf RL Ann Clin Lab Sci; 2007; 37(4):301-14. PubMed ID: 18000286 [TBL] [Abstract][Full Text] [Related]
43. Interferences with urine drug screens. Herring C; Muzyk AJ; Johnston C J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878 [TBL] [Abstract][Full Text] [Related]
44. The role of urine drug testing for patients on opioid therapy. Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D; Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503 [TBL] [Abstract][Full Text] [Related]
45. Utility of oral fluid in compliance monitoring of opioid medications. Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646 [TBL] [Abstract][Full Text] [Related]
46. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain. Setnik B; Roland CL; Pixton GC; Sommerville KW Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769 [TBL] [Abstract][Full Text] [Related]
47. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain. Appa A; McMahan VM; Long K; Shade SB; Coffin PO Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963 [TBL] [Abstract][Full Text] [Related]
48. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database. Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933 [TBL] [Abstract][Full Text] [Related]
49. Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids. Suzuki J; Garayalde S; Dodoo M; Rodriguez C Subst Abus; 2018; 39(4):518-521. PubMed ID: 29697313 [TBL] [Abstract][Full Text] [Related]
50. Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine. Guo AY; Ma JD; Best BM; Atayee RS J Anal Toxicol; 2013; 37(9):636-41. PubMed ID: 24080973 [TBL] [Abstract][Full Text] [Related]
51. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013 [TBL] [Abstract][Full Text] [Related]
52. Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program. Ramey OL; Bonny AE; Silva Almodóvar A; Nahata MC J Adolesc Health; 2023 Jul; 73(1):141-147. PubMed ID: 37031090 [TBL] [Abstract][Full Text] [Related]
53. A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing. Kirsh KL; Baxter LE; Rzetelny A; Mazuk M; Passik SD J Addict Med; 2015; 9(5):399-404. PubMed ID: 26335003 [TBL] [Abstract][Full Text] [Related]